A detailed history of Alps Advisors Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Alps Advisors Inc holds 67,445 shares of ABT stock, worth $7.01 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
67,445
Previous 66,563 1.33%
Holding current value
$7.01 Million
Previous $7.33 Million 4.63%
% of portfolio
0.05%
Previous 0.06%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$109.52 - $120.96 $96,596 - $106,686
882 Added 1.33%
67,445 $7.67 Million
Q4 2023

Feb 14, 2024

BUY
$90.19 - $110.4 $29,852 - $36,542
331 Added 0.5%
66,563 $7.33 Million
Q3 2023

Nov 14, 2023

SELL
$95.53 - $114.62 $2.6 Million - $3.12 Million
-27,226 Reduced 29.13%
66,232 $6.41 Million
Q2 2023

Aug 14, 2023

SELL
$100.78 - $112.29 $472,960 - $526,976
-4,693 Reduced 4.78%
93,458 $10.2 Million
Q1 2023

May 10, 2023

SELL
$96.86 - $114.01 $784,469 - $923,366
-8,099 Reduced 7.62%
98,151 $9.94 Million
Q4 2022

Feb 14, 2023

SELL
$95.06 - $111.52 $502,677 - $589,717
-5,288 Reduced 4.74%
106,250 $11.7 Million
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $2.66 Million - $3.08 Million
-27,488 Reduced 19.77%
111,538 $10.8 Million
Q2 2022

Aug 11, 2022

BUY
$102.07 - $123.37 $13.6 Million - $16.5 Million
133,426 Added 2382.61%
139,026 $15.1 Million
Q1 2022

May 16, 2022

SELL
$114.02 - $139.04 $81,866 - $99,830
-718 Reduced 11.36%
5,600 $663,000
Q4 2021

Feb 09, 2022

BUY
$115.53 - $141.46 $399,502 - $489,168
3,458 Added 120.91%
6,318 $889,000
Q3 2021

Nov 15, 2021

SELL
$116.66 - $129.06 $369,812 - $409,120
-3,170 Reduced 52.57%
2,860 $338,000
Q2 2021

Aug 11, 2021

BUY
$105.79 - $124.53 $137,527 - $161,889
1,300 Added 27.48%
6,030 $699,000
Q1 2021

May 07, 2021

BUY
$108.84 - $128.23 $59,862 - $70,526
550 Added 13.16%
4,730 $567,000
Q4 2020

Feb 03, 2021

BUY
$105.0 - $114.42 $52,605 - $57,324
501 Added 13.62%
4,180 $458,000
Q3 2020

Nov 04, 2020

BUY
$91.64 - $111.29 $103,828 - $126,091
1,133 Added 44.5%
3,679 $400,000
Q2 2020

Aug 05, 2020

SELL
$76.57 - $98.0 $21,592 - $27,636
-282 Reduced 9.97%
2,546 $233,000
Q1 2020

May 06, 2020

SELL
$62.82 - $91.86 $874,642 - $1.28 Million
-13,923 Reduced 83.12%
2,828 $223,000
Q4 2019

Feb 07, 2020

SELL
$78.51 - $87.4 $83,848 - $93,343
-1,068 Reduced 5.99%
16,751 $1.46 Million
Q3 2019

Nov 04, 2019

SELL
$81.84 - $88.74 $19,068 - $20,676
-233 Reduced 1.29%
17,819 $1.49 Million
Q2 2019

Aug 07, 2019

SELL
$72.88 - $85.0 $290,645 - $338,980
-3,988 Reduced 18.09%
18,052 $1.52 Million
Q1 2019

May 01, 2019

SELL
$66.22 - $80.06 $67,279 - $81,340
-1,016 Reduced 4.41%
22,040 $1.76 Million
Q4 2018

Feb 04, 2019

SELL
$65.56 - $74.27 $54,218 - $61,421
-827 Reduced 3.46%
23,056 $1.67 Million
Q3 2018

Oct 25, 2018

BUY
$60.81 - $73.36 $387,298 - $467,229
6,369 Added 36.37%
23,883 $1.75 Million
Q2 2018

Aug 02, 2018

BUY
$57.57 - $63.54 $1.01 Million - $1.11 Million
17,514 New
17,514 $1.07 Million
Q2 2018

Jul 25, 2018

SELL
$57.57 - $63.54 $915,535 - $1.01 Million
-15,903 Closed
0 $0
Q1 2018

May 01, 2018

BUY
$56.27 - $63.62 $894,861 - $1.01 Million
15,903 New
15,903 $953,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $182B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.